Efalizumab for patients with moderate to severe plaque psoriasis: a randomized controlled trial. (Q53361774)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Efalizumab for patients with moderate to severe plaque psoriasis: a randomized controlled trial. |
scientific article |
Statements
Efalizumab for patients with moderate to severe plaque psoriasis: a randomized controlled trial (English)
Kenneth B Gordon
Tiffani K Hamilton
Patricia A Walicke
Wolfgang Dummer
Nicole Li
Brian W Bresnahan
Alan Menter
Efalizumab Study Group
1 December 2003